3billion is open for research collaboration on the topics below.
Clinical validation of rare disease genetic testing
We support the clinical study of rare disease diagnosis by genetic testing. Ask a research collaboration if you are a physician and in need of a diagnosis of rare patients.
Reanalyses of rare patients’ genomes
Patients undiagnosed from the previous genetic testing have a chance to get diagnosed from reanalyses on newly discovered genetic diseases and updated evidences. 3billion helps you diagnose those patients by reanalyses.
Development of genome analysis technology
We improve the genome analysis technology including variant calling, annotation, interpretation, etc.
Development of AI technologies for rare disease drug discovery
We aim to develop AI technologies to revolutionize the rare disease drug discovery, especially on novel target discovery, drug candidate generation, and safety estimation at Phase I level.